Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
WuXi AppTec Co., Ltd. Class H (HK:2359)
HKEX:2359
Holding HK:2359?
Track your performance easily
2359 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$27.50 - HK$103.60
Previous CloseHK$37.8
Volume2.07M
Average Volume (3M)5.97M
Market Cap
HK$125.47B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)10.7
Beta0.87
Next Earnings
Oct 31, 2024EPS Estimate
HK$0.91Last Dividend Ex-Date
Jun 17, 2024Dividend Yield2.88%
Share Statistics
EPS (TTM)3.55
Shares OutstandingN/A
10 Day Avg. Volume7,631,115
30 Day Avg. Volume5,972,456
Standard Deviation0.14
R-Squared0.17
Alpha0.00721
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.67
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$58.66Price Target Upside55.19% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
WuXi AppTec Co., Ltd. Class H News
PremiumCompany Announcements
WuXi AppTec Launches Third Share Buyback in 2024
PremiumCompany Announcements
WuXi AppTec Responds to U.S. House Legislation
PremiumCompany Announcements
WuXi AppTec Reports Decrease in Mid-Year Profits
PremiumCompany Announcements
WuXi AppTec Cancels Thousands of Share Options
PremiumCompany Announcements
WuXi AppTec Schedules Mid-Year Financial ReviewPremiumCompany Announcements
WuXi AppTec’s Share Options Exercise Completes
PremiumCompany Announcements
WuXi AppTec Announces New Share Awards
PremiumCompany Announcements
WuXi AppTec Declares Final Dividend for 2023Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
16.37% Mutual Funds
8.36% Other Institutional Investors
75.27% Public Companies and
Individual Investors
2359 FAQ
What was WuXi AppTec Co., Ltd. Class H’s price range in the past 12 months?
WuXi AppTec Co., Ltd. Class H lowest stock price was HK$27.50 and its highest was HK$103.60 in the past 12 months.
What is WuXi AppTec Co., Ltd. Class H’s market cap?
Currently, no data Available
When is WuXi AppTec Co., Ltd. Class H’s upcoming earnings report date?
WuXi AppTec Co., Ltd. Class H’s upcoming earnings report date is Oct 31, 2024 which is in 41 days.
How were WuXi AppTec Co., Ltd. Class H’s earnings last quarter?
WuXi AppTec Co., Ltd. Class H released its earnings results on Jul 29, 2024. The company reported HK$0.85 earnings per share for the quarter, beating the consensus estimate of HK$0.839 by HK$0.011.
Is WuXi AppTec Co., Ltd. Class H overvalued?
According to Wall Street analysts WuXi AppTec Co., Ltd. Class H’s price is currently Undervalued.
Does WuXi AppTec Co., Ltd. Class H pay dividends?
WuXi AppTec Co., Ltd. Class H pays a Annually dividend of HK$1.06 which represents an annual dividend yield of 2.88%. See more information on WuXi AppTec Co., Ltd. Class H dividends here
What is WuXi AppTec Co., Ltd. Class H’s EPS estimate?
WuXi AppTec Co., Ltd. Class H’s EPS estimate is HK$0.91.
How many shares outstanding does WuXi AppTec Co., Ltd. Class H have?
WuXi AppTec Co., Ltd. Class H has 387,076,140 shares outstanding.
What happened to WuXi AppTec Co., Ltd. Class H’s price movement after its last earnings report?
WuXi AppTec Co., Ltd. Class H reported an EPS of HK$0.85 in its last earnings report, beating expectations of HK$0.839. Following the earnings report the stock price went up 0.349%.
Which hedge fund is a major shareholder of WuXi AppTec Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2359
---
WuXi AppTec Co., Ltd. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
18.49%
Trailing 12-Months
Asset Growth
6.90%
Trailing 12-Months
Company Description
WuXi AppTec Co., Ltd. Class H
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.
---
2359 Stock 12 Month Forecast
Average Price Target
HK$58.66
▲(55.19% Upside)
Technical Analysis
Best Analysts Covering 2359
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-26.40%
reiterated a buy rating 2 months ago
Copying Chris Lui's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -26.40% per trade.
---